investor losses

Aldeyra Therapeutics faces securities fraud lawsuit alleging it concealed reproxalap trial data inconsistencies, leading to 70.7% stock collapse after FDA rejection in March 2026.

Schall Law Firm files class action against $NAVN for allegedly concealing post-IPO sales and marketing expenditure needs during October 2025 IPO.

Schall Law Firm initiates securities fraud class action against uniQure ($QURE) over alleged false FDA approval statements and misleading BLA timelines.

Robbins Geller files class action against $MEDP over alleged false book-to-bill projections. Stock fell 16% after Q4 miss. Lead plaintiff deadline: June 8, 2026.

Power Solutions International faces securities lawsuit over alleged data center market misstatements. Lead plaintiff deadline set for May 19, 2026.

Rosen Law Firm seeks $SMCI investors with losses exceeding $100K in securities lawsuit alleging false statements regarding Chinese company sales and compliance failures.

Rosen Law Firm filed class action lawsuit against $ALDX alleging false statements. Investors with $100K+ losses urged to join before deadline.

Rosen Law Firm files securities class action against Trip.com Group Limited ($TCOM), urging investors with losses exceeding $100K to secure counsel before May 11, 2026 deadline.

Securities lawsuit alleges Atara Biotherapeutics concealed manufacturing issues and clinical study deficiencies for tabelecleucel. Investors with $100K+ losses must act before May 22, 2026 deadline.

Class action lawsuit filed against New Era Energy & Digital over alleged false statements regarding Texas data centers and fraudulent oil/gas scheme in New Mexico.

Barclays faces class action investigation over £600M undisclosed exposure to collapsed UK mortgage lender, triggering stock declines and regulatory scrutiny.

America's Car-Mart ($CRMT) stock fell 18.2% after disappointing earnings. Securities lawyers are investigating alleged misleading disclosures and preparing class action lawsuits.

PennyMac Financial Services ($PFSI) stock crashed 33.3% following weak Q4 earnings, prompting securities litigation over allegedly misleading disclosures.

Eos Energy faces class action over alleged false statements about production capacity and quality targets; investors have until May 6, 2026 to participate.

Immutep's $IMMP stock crashed 82.6% after discontinuing Phase III trial for lead drug candidate. Rosen Law Firm investigating potential securities violations and class action claims.

Rosen Law Firm urges Kyndryl investors with $100K+ losses to meet April 13, 2026 lead plaintiff deadline in securities class action alleging financial misstatements and control deficiencies.

ImmunityBio faces securities lawsuit after FDA warning letter regarding misleading efficacy claims for immunotherapy drug Anktiva, triggering 21% stock plunge.

Rosen Law Firm files securities class action against Franklin BSP Realty Trust ($FBRT) over alleged misstatements on dividends; April 2026 deadline for lead plaintiff participation.

Eos Energy ($EOSE) faces securities lawsuit over false scaling statements and undisclosed manufacturing problems. Stock plunged 39% after missing revenue targets.

GSI Technology faces securities investigation after allegations of misleading statements about AI chip capabilities. Stock fell 14.2% following February disclosure.